Riskpilot← Back to searchSign inGet full accessGemCap Biotech ApS
APSDissolvedCVR 38189174Lyngby Hovedgade 10COther financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2016— employees
Revenue 2023
—
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2023
DKK 0
| Revenue | — | — |
| EBITDA | DKK 0 | — |
| Net profit | DKK 0 | — |
| Total assets | DKK 27K | +0% |
| Equity | DKK 27K | +0% |
| Employees | — | — |
Legal name
GemCap Biotech ApS
CVR number
38189174
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
17. november 2016
Share capital
DKK 27.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør i forening med et bestyrelsesmedlem eller af to bestyrelsesmedlemmer i
forening eller af den samlede bestyrelse.
Address
Lyngby Hovedgade 10C
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Total assets | 7 | 7 | 7 | 7 | 7 | 27 | 27 |
| Equity | 7 | 7 | 7 | 7 | 7 | 27 | 27 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20172023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20172023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20172023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-11-17 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KH Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NorthCapital Holding ApS | Company | 100.0% | 100.0% | 2017 |
GemCap ApS | Company | 100.0% | 100.0% | 2019 |
GemCap International ApS | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GemCap Biotech ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kim Hersland | Chief Executive Officer | 0 companies |
| Werner Schmidt | Board of Directors | 0 companies |
| Werner Ernst Spiegler | Board of Directors | 0 companies |
| Christian Frederik Harboe Wissum | Chairman | 0 companies |